TY - JOUR
T1 - Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes
AU - Oresic, Matej
AU - Simell, Satu
AU - Sysi-Aho, Marko
AU - Näntö-Salonen, Kirsti
AU - Seppänen-Laakso, Tuulikki
AU - Parikka, Vilhelmiina
AU - Katajamaa, Mikko
AU - Hekkala, Anne
AU - Mattila, Ismo
AU - Keskinen, Päivi
AU - Yetukuri, Laxman
AU - Reinikainen, Arja
AU - Lähde, Jyrki
AU - Suortti, Tapani
AU - Hakalax, Jari
AU - Simell, Tuula
AU - Hyöty, Heikki
AU - Veijola, Riitta
AU - Ilonen, Jorma
AU - Lahesmaa, Riitta
AU - Knip, Mikael
AU - Simell, Olli
PY - 2008
Y1 - 2008
N2 - The risk determinants of type 1 diabetes, initiators of autoimmune response, mechanisms regulating progress toward β cell failure, and factors determining time of presentation of clinical diabetes are poorly understood. We investigated changes in the serum metabolome prospectively in children who later progressed to type 1 diabetes. Serum metabolite profiles were compared between sample series drawn from 56 children who progressed to type 1 diabetes and 73 controls who remained nondiabetic and permanently autoantibody negative. Individuals who developed diabetes had reduced serum levels of succinic acid and phosphatidylcholine (PC) at birth, reduced levels of triglycerides and antioxidant ether phospholipids throughout the follow up, and increased levels of proinflammatory lysoPCs several months before seroconversion to autoantibody positivity. The lipid changes were not attributable to HLA-associated genetic risk. The appearance of insulin and glutamic acid decarboxylase autoantibodies was preceded by diminished ketoleucine and elevated glutamic acid. The metabolic profile was partially normalized after the seroconversion. Autoimmunity may thus be a relatively late response to the early metabolic disturbances. Recognition of these preautoimmune alterations may aid in studies of disease pathogenesis and may open a time window for novel type 1 diabetes prevention strategies.
AB - The risk determinants of type 1 diabetes, initiators of autoimmune response, mechanisms regulating progress toward β cell failure, and factors determining time of presentation of clinical diabetes are poorly understood. We investigated changes in the serum metabolome prospectively in children who later progressed to type 1 diabetes. Serum metabolite profiles were compared between sample series drawn from 56 children who progressed to type 1 diabetes and 73 controls who remained nondiabetic and permanently autoantibody negative. Individuals who developed diabetes had reduced serum levels of succinic acid and phosphatidylcholine (PC) at birth, reduced levels of triglycerides and antioxidant ether phospholipids throughout the follow up, and increased levels of proinflammatory lysoPCs several months before seroconversion to autoantibody positivity. The lipid changes were not attributable to HLA-associated genetic risk. The appearance of insulin and glutamic acid decarboxylase autoantibodies was preceded by diminished ketoleucine and elevated glutamic acid. The metabolic profile was partially normalized after the seroconversion. Autoimmunity may thus be a relatively late response to the early metabolic disturbances. Recognition of these preautoimmune alterations may aid in studies of disease pathogenesis and may open a time window for novel type 1 diabetes prevention strategies.
U2 - 10.1084/jem.20081800
DO - 10.1084/jem.20081800
M3 - Article
SN - 0022-1007
VL - 205
SP - 2975
EP - 2984
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 13
ER -